Journal article 964 views
Ran Is a Potential Therapeutic Target for Cancer Cells with Molecular Changes Associated with Activation of the PI3K/Akt/mTORC1 and Ras/MEK/ERK Pathways
Hiu-Fung Yuen,
Ka-Kui Chan,
Claire Grills,
James Murray
,
Angela Platt-Higgins,
Osama Sharaf Eldin,
Ken O'Byrne,
Pasi Janne,
Dean A. Fennell,
Patrick G. Johnston,
Philip S. Rudland,
Mohamed El-Tanani
Clinical Cancer Research, Volume: 18, Issue: 2, Pages: 380 - 391
Swansea University Author:
James Murray
Full text not available from this repository: check for access using links below.
DOI (Published version): 10.1158/1078-0432.ccr-11-2035
Abstract
Ran Is a Potential Therapeutic Target for Cancer Cells with Molecular Changes Associated with Activation of the PI3K/Akt/mTORC1 and Ras/MEK/ERK Pathways
| Published in: | Clinical Cancer Research |
|---|---|
| ISSN: | 1078-0432 1557-3265 |
| Published: |
American Association for Cancer Research (AACR)
2012
|
| Online Access: |
Check full text
|
| URI: | https://cronfa.swan.ac.uk/Record/cronfa56416 |
| first_indexed |
2021-03-23T15:47:18Z |
|---|---|
| last_indexed |
2021-03-24T04:22:07Z |
| id |
cronfa56416 |
| recordtype |
SURis |
| fullrecord |
<?xml version="1.0"?><rfc1807><datestamp>2021-03-23T15:48:13.1718004</datestamp><bib-version>v2</bib-version><id>56416</id><entry>2021-03-11</entry><title>Ran Is a Potential Therapeutic Target for Cancer Cells with Molecular Changes Associated with Activation of the PI3K/Akt/mTORC1 and Ras/MEK/ERK Pathways</title><swanseaauthors><author><sid>12d0a585fcfe66f83c4c21c6bca3197b</sid><ORCID>0000-0002-6928-2347</ORCID><firstname>James</firstname><surname>Murray</surname><name>James Murray</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2021-03-11</date><deptcode>MEDS</deptcode><abstract/><type>Journal Article</type><journal>Clinical Cancer Research</journal><volume>18</volume><journalNumber>2</journalNumber><paginationStart>380</paginationStart><paginationEnd>391</paginationEnd><publisher>American Association for Cancer Research (AACR)</publisher><placeOfPublication/><isbnPrint/><isbnElectronic/><issnPrint>1078-0432</issnPrint><issnElectronic>1557-3265</issnElectronic><keywords/><publishedDay>15</publishedDay><publishedMonth>1</publishedMonth><publishedYear>2012</publishedYear><publishedDate>2012-01-15</publishedDate><doi>10.1158/1078-0432.ccr-11-2035</doi><url/><notes/><college>COLLEGE NANME</college><department>Medical School</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>MEDS</DepartmentCode><institution>Swansea University</institution><apcterm/><lastEdited>2021-03-23T15:48:13.1718004</lastEdited><Created>2021-03-11T10:12:46.9571414</Created><path><level id="1">Faculty of Medicine, Health and Life Sciences</level><level id="2">Swansea University Medical School - Medicine</level></path><authors><author><firstname>Hiu-Fung</firstname><surname>Yuen</surname><order>1</order></author><author><firstname>Ka-Kui</firstname><surname>Chan</surname><order>2</order></author><author><firstname>Claire</firstname><surname>Grills</surname><order>3</order></author><author><firstname>James</firstname><surname>Murray</surname><orcid>0000-0002-6928-2347</orcid><order>4</order></author><author><firstname>Angela</firstname><surname>Platt-Higgins</surname><order>5</order></author><author><firstname>Osama Sharaf</firstname><surname>Eldin</surname><order>6</order></author><author><firstname>Ken</firstname><surname>O'Byrne</surname><order>7</order></author><author><firstname>Pasi</firstname><surname>Janne</surname><order>8</order></author><author><firstname>Dean A.</firstname><surname>Fennell</surname><order>9</order></author><author><firstname>Patrick G.</firstname><surname>Johnston</surname><order>10</order></author><author><firstname>Philip S.</firstname><surname>Rudland</surname><order>11</order></author><author><firstname>Mohamed</firstname><surname>El-Tanani</surname><order>12</order></author></authors><documents/><OutputDurs/></rfc1807> |
| spelling |
2021-03-23T15:48:13.1718004 v2 56416 2021-03-11 Ran Is a Potential Therapeutic Target for Cancer Cells with Molecular Changes Associated with Activation of the PI3K/Akt/mTORC1 and Ras/MEK/ERK Pathways 12d0a585fcfe66f83c4c21c6bca3197b 0000-0002-6928-2347 James Murray James Murray true false 2021-03-11 MEDS Journal Article Clinical Cancer Research 18 2 380 391 American Association for Cancer Research (AACR) 1078-0432 1557-3265 15 1 2012 2012-01-15 10.1158/1078-0432.ccr-11-2035 COLLEGE NANME Medical School COLLEGE CODE MEDS Swansea University 2021-03-23T15:48:13.1718004 2021-03-11T10:12:46.9571414 Faculty of Medicine, Health and Life Sciences Swansea University Medical School - Medicine Hiu-Fung Yuen 1 Ka-Kui Chan 2 Claire Grills 3 James Murray 0000-0002-6928-2347 4 Angela Platt-Higgins 5 Osama Sharaf Eldin 6 Ken O'Byrne 7 Pasi Janne 8 Dean A. Fennell 9 Patrick G. Johnston 10 Philip S. Rudland 11 Mohamed El-Tanani 12 |
| title |
Ran Is a Potential Therapeutic Target for Cancer Cells with Molecular Changes Associated with Activation of the PI3K/Akt/mTORC1 and Ras/MEK/ERK Pathways |
| spellingShingle |
Ran Is a Potential Therapeutic Target for Cancer Cells with Molecular Changes Associated with Activation of the PI3K/Akt/mTORC1 and Ras/MEK/ERK Pathways James Murray |
| title_short |
Ran Is a Potential Therapeutic Target for Cancer Cells with Molecular Changes Associated with Activation of the PI3K/Akt/mTORC1 and Ras/MEK/ERK Pathways |
| title_full |
Ran Is a Potential Therapeutic Target for Cancer Cells with Molecular Changes Associated with Activation of the PI3K/Akt/mTORC1 and Ras/MEK/ERK Pathways |
| title_fullStr |
Ran Is a Potential Therapeutic Target for Cancer Cells with Molecular Changes Associated with Activation of the PI3K/Akt/mTORC1 and Ras/MEK/ERK Pathways |
| title_full_unstemmed |
Ran Is a Potential Therapeutic Target for Cancer Cells with Molecular Changes Associated with Activation of the PI3K/Akt/mTORC1 and Ras/MEK/ERK Pathways |
| title_sort |
Ran Is a Potential Therapeutic Target for Cancer Cells with Molecular Changes Associated with Activation of the PI3K/Akt/mTORC1 and Ras/MEK/ERK Pathways |
| author_id_str_mv |
12d0a585fcfe66f83c4c21c6bca3197b |
| author_id_fullname_str_mv |
12d0a585fcfe66f83c4c21c6bca3197b_***_James Murray |
| author |
James Murray |
| author2 |
Hiu-Fung Yuen Ka-Kui Chan Claire Grills James Murray Angela Platt-Higgins Osama Sharaf Eldin Ken O'Byrne Pasi Janne Dean A. Fennell Patrick G. Johnston Philip S. Rudland Mohamed El-Tanani |
| format |
Journal article |
| container_title |
Clinical Cancer Research |
| container_volume |
18 |
| container_issue |
2 |
| container_start_page |
380 |
| publishDate |
2012 |
| institution |
Swansea University |
| issn |
1078-0432 1557-3265 |
| doi_str_mv |
10.1158/1078-0432.ccr-11-2035 |
| publisher |
American Association for Cancer Research (AACR) |
| college_str |
Faculty of Medicine, Health and Life Sciences |
| hierarchytype |
|
| hierarchy_top_id |
facultyofmedicinehealthandlifesciences |
| hierarchy_top_title |
Faculty of Medicine, Health and Life Sciences |
| hierarchy_parent_id |
facultyofmedicinehealthandlifesciences |
| hierarchy_parent_title |
Faculty of Medicine, Health and Life Sciences |
| department_str |
Swansea University Medical School - Medicine{{{_:::_}}}Faculty of Medicine, Health and Life Sciences{{{_:::_}}}Swansea University Medical School - Medicine |
| document_store_str |
0 |
| active_str |
0 |
| published_date |
2012-01-15T04:52:41Z |
| _version_ |
1851367423505072128 |
| score |
11.089572 |

